Aroa Biosurgery Ltd
ASX:ARX
Aroa Biosurgery Ltd
ASX:ARX
Price:
0.68
AUD
-3.55%
Market Closed
Market Cap:
AU$234.9m
Balance Sheet
Balance Sheet Decomposition
Aroa Biosurgery Ltd
Aroa Biosurgery Ltd
Balance Sheet Decomposition is not available for
Aroa Biosurgery Ltd
Aroa Biosurgery Ltd
Balance Sheet
Aroa Biosurgery Ltd
Aroa Biosurgery Ltd
Currency: NZD
| Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
4
|
4
|
4
|
15
|
6
|
10
|
12
|
8
|
|
| Cash |
4
|
4
|
4
|
15
|
6
|
10
|
12
|
8
|
|
| Short-Term Investments |
0
|
0
|
1
|
22
|
51
|
36
|
19
|
14
|
|
| Total Receivables |
3
|
5
|
7
|
7
|
17
|
26
|
29
|
35
|
|
| Accounts Receivables |
1
|
3
|
4
|
3
|
10
|
23
|
26
|
34
|
|
| Other Receivables |
1
|
2
|
3
|
4
|
7
|
3
|
3
|
2
|
|
| Inventory |
2
|
3
|
4
|
4
|
4
|
5
|
8
|
8
|
|
| Other Current Assets |
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
|
| Total Current Assets |
9
|
13
|
18
|
49
|
80
|
78
|
69
|
68
|
|
| PP&E Net |
5
|
6
|
9
|
13
|
15
|
21
|
22
|
22
|
|
| PP&E Gross |
5
|
6
|
9
|
13
|
15
|
21
|
22
|
22
|
|
| Accumulated Depreciation |
2
|
3
|
4
|
5
|
6
|
8
|
10
|
12
|
|
| Intangible Assets |
0
|
15
|
14
|
13
|
12
|
12
|
14
|
14
|
|
| Goodwill |
0
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Assets |
15
N/A
|
39
+159%
|
46
+16%
|
80
+73%
|
113
+41%
|
117
+3%
|
111
-5%
|
109
-2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Accrued Liabilities |
1
|
2
|
4
|
4
|
5
|
5
|
6
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
1
|
11
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
1
|
5
|
29
|
0
|
0
|
0
|
1
|
2
|
|
| Total Current Liabilities |
2
|
8
|
35
|
15
|
7
|
8
|
10
|
10
|
|
| Long-Term Debt |
1
|
0
|
3
|
6
|
5
|
7
|
6
|
5
|
|
| Other Liabilities |
10
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
27
+106%
|
38
+40%
|
21
-45%
|
12
-43%
|
15
+20%
|
16
+10%
|
16
-2%
|
|
| Equity | |||||||||
| Common Stock |
20
|
29
|
29
|
97
|
146
|
146
|
147
|
147
|
|
| Retained Earnings |
18
|
17
|
23
|
41
|
46
|
44
|
52
|
54
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
1
|
2
|
1
|
1
|
1
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Total Equity |
2
N/A
|
12
+538%
|
8
-37%
|
58
+669%
|
100
+72%
|
102
+1%
|
95
-7%
|
93
-2%
|
|
| Total Liabilities & Equity |
15
N/A
|
39
+159%
|
46
+16%
|
80
+73%
|
113
+41%
|
117
+3%
|
111
-5%
|
109
-2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
300
|
300
|
300
|
301
|
342
|
343
|
344
|
345
|
|
Switch to:
Switch to:
See Also
Discover More
